VitamIn and oXygen Interventions and Cardiovascular Events

University Hospital Bispebjerg and Frederiksberg600 enrolled

Overview

This study examines the risks and benefits of antioxidants and normal versus high inspiratory oxygen fraction during anaesthesia.

Adult patients with risk factors for developing postoperative cardiac complications will be enrolled in the study. The patients will be randomised to receiving antioxidants or placebo perioperatively and 30% or 80% inspiratory oxygen concentration during anaesthesia and 2 hours postoperatively. The primary outcome is MINS (myocardial injury after non-cardiac surgery). The antioxidants are ascorbic acid (vitamin C) 3 grams intravenously preoperatively and N-acetylcysteine 100 milligrams/kilogram body weight intravenous infusion for 4 hours, starting at the same time as anaesthesia. The study is a long-term follow-up study of the risk of mortality, MI and readmissions performed at 1 year after inclusion of the last patient. Two other follow-up studies are planned: One investigation of ischaemic troponin elevations defined as peak troponin levels above the internationally defined thresholds without extracardiac causes; another investigating the intervention effects in the subgroup of patients undergoing vascular surgery with specific emphasis on episodes of intraoperative hypotension within the following thresholds: MAP below 70 mmHg, 65 mmHg, 60 mmHg and 55 mmHg.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

DOUBLE

Enrollment

600

Conditions

Postoperative Cardiac Complication

Interventions

OxygenDRUG

80% versus 30% inspiratory oxygen concentration

AntioxidantsDRUG

Antioxidants versus placebo

Eligibility

Sex: ALLMin age: 45 Years

Medical Language ↔ Plain English

Inclusion criteria: All of the listed criteria (1.-4.) must be met. 1. Age 45 years or above 2. Elective or acute surgery in general anaesthesia 3. Scheduled for abdominal, orthopaedic, or vascular surgery with expected surgery duration of one hour or more. 4. Fulfil any 1 of the following 5 criteria: 1. \- History of coronary artery disease including angina 2. \- History of stroke 3. \- Undergoing vascular surgery 4. \- History of peripheral arterial disease 5. \- Any 2 of the following 8 criteria: i. Acute surgery ii. Current or previous daily smoking iii. History of hypertension iv. Diabetes mellitus requiring medical treatment v. History of transient cerebral ischemia vi. Plasma creatinine \>175 µM vii. Age 70 years or above viii. History of congestive heart failure Exclusion criteria: 1. Surgery within 30 days prior to operation 2. Arterial oxygen saturation below 90% without oxygen supplementation 3. Inability to give informed consent 4. Drug allergy towards any of the drugs involved in the trial 5. Previous treatment with bleomycin 6. Pregnancy

Locations (4)

Abdominalcentret, Rigshospitalet

Copenhagen, Denmark

HovedOrtoCentret, Rigshospitalet

Copenhagen, Denmark

Bispebjerg and Frederiksberg Hospital, University of Copenhagen

Copenhagen, Denmark

Herlev Hospital

Herlev, Denmark

Outcomes

Primary Outcomes

Myocardial injury after non-cardiac surgery (MINS)

Troponin measurement the first 3 postoperative days. Assessed by area under the curve.

Time frame: 30 days

Secondary Outcomes

Mortality

Assessed as time to event analysis

Time frame: During the study period until completion of last visit of last patient

Non-fatal myocardial infarction

Assessed as time to event analysis

Time frame: During the study period until completion of last visit of last patient

Non-fatal Serious Adverse Event

Assessed as time to event analysis

Time frame: During the study period until completion of last visit of last patient

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.